Osteoporosis Trial, Recruiting NCT03461237 Sponsor: Beijing Jishuitan Hospital Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT03461237
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with osteoporosis (a condition that weakens bones)
  • You have had a hip fracture due to osteoporosis (specifically a break at the top of the thigh bone, either at the neck or the trochanter region)
  • You are willing and able to take part in the study and have signed a consent form agreeing to participate

Who may not be able to join:

  • You are under 47 years old
  • Your hip fracture is not being treated with surgery
  • Your fracture was caused by a disease (such as cancer affecting the bone) rather than by weakened bones (confirm with trial site)
  • Your fracture was caused by a violent injury or accident
  • You already have implants or a hip replacement in both hips, or you have had a hip replacement on the hip that was NOT fractured

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiaoguang Cheng, MD, department of radiology, Beijing Jishuitan Hospital

Phone: 0086-010-58516947

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Jishuitan Hospital
Registry
ClinicalTrials.gov
Start date
1 May 2017
Est. completion
1 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Hip re-fracture; all cause death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov